NCT02317276View on ClinicalTrials.gov

A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal

PHASE4TerminatedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

April 6, 2017

Study Completion Date

April 6, 2017

Conditions

Dermatitis, Atopic

Interventions

DRUG

Triamcinolone 0.1%

Topical ointment

Trial Locations (1)

94115

UCSF Dermatology, San Francisco

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of California, San Francisco

OTHER